BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1969221)

  • 1. Evidence that action potential-induced Ca2+ influx is necessary but not sufficient to release transmitter from sympathetic nerve terminals.
    Msghina M; Stjärne E; Astrand P; Stjärne L
    Acta Physiol Scand; 1990 Feb; 138(2):239-40. PubMed ID: 1969221
    [No Abstract]   [Full Text] [Related]  

  • 2. K+ and Ca2+ channel blocking agents increase or decrease stimulus-evoked but not spontaneous quantal transmitter release in sympathetic nerve terminals.
    Stjärne L; Msghina M; Stjärne E
    Acta Physiol Scand; 1990 Feb; 138(2):235-7. PubMed ID: 2156406
    [No Abstract]   [Full Text] [Related]  

  • 3. Do alpha 2-agonists inhibit sympathetic transmitter secretion in part by depressing a Ca2+ component of the nerve impulse 'upstream' of varicosities?
    Stjärne C; Stjärne E; Msghina M
    Acta Physiol Scand; 1988 Aug; 133(4):591-2. PubMed ID: 2906514
    [No Abstract]   [Full Text] [Related]  

  • 4. Potassium channel blocking agents induce occasional spontaneous action potentials and multiquantal ATP release in sympathetic nerve terminals.
    Msghina M; Stjärne E; Stjärne L
    Acta Physiol Scand; 1989 Apr; 135(4):593-4. PubMed ID: 2544080
    [No Abstract]   [Full Text] [Related]  

  • 5. Synaptic transmission in the guinea-pig vas deferens: the role of nerve action potentials.
    Cheung DW
    Neuroscience; 1990; 37(1):127-34. PubMed ID: 1978738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency dependent intermittency and ionic basis of impulse conduction in postganglionic sympathetic fibres of guinea-pig vas deferens.
    Cunnane TC; Stjärne L
    Neuroscience; 1984 Jan; 11(1):211-29. PubMed ID: 6324028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-conotoxin GVIA-resistant neurotransmitter release from postganglionic sympathetic nerves in the guinea-pig vas deferens and its modulation by presynaptic receptors.
    Smith AB; Cunnane TC
    Br J Pharmacol; 1998 Jan; 123(2):167-72. PubMed ID: 9489603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that alpha 2-agonists may inhibit sympathetic transmitter secretion by an effect 'upstream' of varicosities.
    Stjärne L; Stjärne E
    Acta Physiol Scand; 1988 Jul; 133(3):433-4. PubMed ID: 2906511
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of K+-channel blockers on transmitter release in bullfrog sympathetic ganglia.
    Kumamoto E; Kuba K
    J Pharmacol Exp Ther; 1985 Oct; 235(1):241-7. PubMed ID: 2413197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bretylium abolishes neurotransmitter release without necessarily abolishing the nerve terminal action potential in sympathetic terminals.
    Brain KL; Cunnane TC
    Br J Pharmacol; 2008 Feb; 153(4):831-9. PubMed ID: 18071295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does K+ channel block 'upstream' of varicosities enhance the probability of nerve impulse-induced ATP release from sympathetic nerves by mobilizing Ca2+ from Schwann cells?
    Stjärne L; Stjärne E; Msghina M; Bao JX
    Acta Physiol Scand; 1990 May; 139(1):251-2. PubMed ID: 2356755
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the effect of prostaglandins E1 and E2 on the sympathetic neuromuscular transmission in some animal tissues.
    Hedqvist P
    Acta Physiol Scand Suppl; 1970; 345():1-40. PubMed ID: 4325725
    [No Abstract]   [Full Text] [Related]  

  • 13. Basic features of an extracellular recording method to study secretion of a sympathetic co-transmitter, presumably ATP.
    Stjärne L; Stjärne E
    Acta Physiol Scand; 1989 Mar; 135(3):217-26. PubMed ID: 2564718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is 'upstream' control of sympathetic transmitter release dependent on the length of varicosity strings?
    Stjärne L; Msghina M; Stjärne E
    Acta Physiol Scand; 1989 Oct; 137(2):313-4. PubMed ID: 2575844
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropeptide Y may inhibit sympathetic transmitter secretion by an effect 'upstream' of varicosities.
    Stjärne L; Stjärne E; Mshgina M; Lundberg JM
    Acta Physiol Scand; 1988 Dec; 134(4):577-8. PubMed ID: 2907962
    [No Abstract]   [Full Text] [Related]  

  • 16. Temperature dependence of 'local' and 'upstream' regulation of sympathetic transmitter secretion in mouse vas deferens.
    Stjärne L; Msghina M; Stjärne E; Tanaka E
    Acta Physiol Scand; 1989 Oct; 137(2):311-2. PubMed ID: 2575843
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of nicotine-induced release of norepinephrine from adrenergic nerve endings: is generation and propagation of impulses necessary?
    Jayasundar S; Vohra MM
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):202-10. PubMed ID: 209754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some pharmacological applications of an extracellular recording method to study secretion of a sympathetic co-transmitter, presumably ATP.
    Stjärne L; Stjärne E
    Acta Physiol Scand; 1989 Mar; 135(3):227-39. PubMed ID: 2564719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion of transmitter from individual varicosities of guinea-pig and mouse vas deferens: all-or-none and extremely intermittent.
    Cunnane TC; Stjärne L
    Neuroscience; 1982; 7(11):2565-76. PubMed ID: 6130491
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of morphine on the nerve terminal impulse and transmitter release from sympathetic varicosities innervating the mouse vas deferens.
    Lavidis NA
    Br J Pharmacol; 1995 Dec; 116(7):2852-9. PubMed ID: 8680716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.